Ogawa, Yoshikazu
Takahashi, Nobunori
Kaneko, Atsushi
Hirano, Yuji
Kanayama, Yasuhide
Yabe, Yuichiro
Oguchi, Takeshi
Fujibayashi, Takayoshi
Takagi, Hideki
Hanabayashi, Masahiro
Funahashi, Koji
Hayashi, Masatoshi
Tsuboi, Seiji
Asai, Shuji
Asai, Nobuyuki
Matsumoto, Takuya
Sobue, Yasumori
Ishiguro, Naoki
Kojima, Toshihisa
Article History
Received: 29 March 2019
Revised: 26 May 2019
Accepted: 28 May 2019
First Online: 10 June 2019
Compliance with ethical standards
:
: N.T. has received speaking fees from Abbott Japan Co. Ltd., Eisai Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Bristol-Myers Squibb, Abbott Japan, Chugai Pharmaceutical Co. Ltd., and Pfizer Co. Ltd. N.I. has received lecture fees including service on speaker bureaus from Daiichi Sankyo Company Ltd., Takeda Pharmaceutical Co. Ltd., Taisho Toyama Pharmaceutical Co. Ltd., Kaken Pharmaceutical Co. Ltd., Eisai Co. Ltd., Janssen Pharmaceutical KK, Bristol-Myers Squibb, Abbott Japan, Chugai Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharmaceutical, UCB Japan, and Astellas Pharma Inc. T.K. has received lecture fees from Mitsubishi Tanabe Pharma Corporation, Takeda Pharma Corporation, Bristol-Myers Squibb, Abbott Japan, Chugai Pharmaceutical Co. Ltd., and Eisai Pharma Corporation. All other authors have declared no conflicts of interest.